Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
BIOMARIN PHARMACEUTICAL INC (BMRN)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 0.6 | 0.6 | 0.8 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 |
Asset turnover | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 |
|
Returns on Capital |
ROIC (excluding intangibles) | 0.9% | -1.7% | 46.8% | -1.1% | -3.3% | -17.0% | -6.9% | -19.4% |
ROIC (including intangibles) | 0.8% | -1.4% | 35.4% | -0.9% | -2.7% | -12.6% | -4.8% | -10.8% |
ROE | 0.9% | -1.6% | 40.9% | -1.0% | -3.2% | -16.2% | -5.6% | -13.0% |
ROA | 0.6% | -1.2% | 28.7% | -0.7% | -2.1% | -9.8% | -3.9% | -8.4% |
|
Cash Conversion Cycle |
Days sales outstanding | 80.3 | 73.8 | 88.0 | 80.8 | 83.9 | 72.6 | 70.4 | 67.7 |
Days payables outstanding | | | | | | | | |
Days inventory outstanding | 674.7 | 602.5 | 486.3 | 690.7 | 614.6 | 718.2 | 618.4 | 652.4 |
Cash conversion cycle | 755.1 | 676.3 | 574.3 | 771.6 | 698.5 | 790.9 | 688.7 | 720.0 |
|